HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Izumi Selected Research

Polypeptide N-acetylgalactosaminyltransferase

7/2013Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas.
6/2011Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival.
1/2004Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence.
9/2002N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Izumi Research Topics

Disease

12Neoplasms (Cancer)
02/2015 - 09/2000
2Stomach Neoplasms (Stomach Cancer)
02/2015 - 02/2001
2Neoplasm Metastasis (Metastasis)
02/2015 - 01/2004
2Adenocarcinoma of Lung
05/2014 - 01/2004
2Ganglion Cysts (Ganglion)
03/2008 - 08/2000
2Carcinoma (Carcinomatosis)
01/2004 - 09/2002
2Hemorrhage
11/2003 - 08/2000
2Inflammation (Inflammations)
08/2003 - 07/2000
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2002 - 01/2001
2Lung Neoplasms (Lung Cancer)
09/2002 - 12/2000
2Infections
09/2001 - 08/2000
1Hepatocellular Carcinoma (Hepatoma)
06/2018
1Renal Cell Carcinoma (Grawitz Tumor)
07/2013
1Necrosis
07/2013
1Endometrial Neoplasms (Endometrial Cancer)
01/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2011
1Pneumothorax
04/2011
1Rupture
04/2011
1Blister (Bulla)
04/2011
1Chromosomal Instability (Chromosome Stability)
01/2008
1Glioma (Gliomas)
01/2008
1Prostatic Neoplasms (Prostate Cancer)
08/2007
1Ovarian Neoplasms (Ovarian Cancer)
04/2007
1Testicular Neoplasms (Testicular Cancer)
03/2006
1Lymphatic Metastasis
01/2004
1Pleural Effusion (Pleural Effusions)
08/2003
1Vasculitis (Vasculitides)
08/2003
1Hyperhidrosis
04/2003
1Pain (Aches)
04/2003
1Colorectal Neoplasms (Colorectal Cancer)
12/2001
1Congenital Heart Defects (Congenital Heart Defect)
12/2001
1Hemolytic-Uremic Syndrome
09/2001
1Colitis
09/2001
1Measles
06/2001
1Aneuploidy (Aneuploid)
02/2001
1Pleural Empyema (Pyothorax)
12/2000
1Pulmonary Emphysema
12/2000
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2000
1Fistula
12/2000
1Fibrosarcoma
09/2000
1Ischemia
08/2000

Drug/Important Bio-Agent (IBA)

4Polypeptide N-acetylgalactosaminyltransferaseIBA
07/2013 - 09/2002
3Peptides (Polypeptides)IBA
07/2013 - 01/2004
3Cisplatin (Platino)FDA LinkGeneric
08/2007 - 02/2001
2Y-Box-Binding Protein 1IBA
02/2015 - 04/2007
2Proteins (Proteins, Gene)FDA Link
05/2014 - 07/2013
2N-AcetylgalactosaminyltransferasesIBA
07/2013 - 06/2011
2Fibrin Tissue Adhesive (Fibrin Sealant)IBA
04/2011 - 12/2000
1MicroRNAs (MicroRNA)IBA
06/2018
1Biomarkers (Surrogate Marker)IBA
02/2015
1ParaffinIBA
05/2014
1TransferasesIBA
07/2013
1UDP-N-acetylgalactosamine polypeptide N-acetylgalactosaminyltransferase 6IBA
06/2011
1Protein Isoforms (Isoforms)IBA
06/2011
1methanesulfonate salt 2-hydroxy-4,4'-diamidinostilbeneIBA
03/2008
1SurvivinIBA
01/2008
1Vincristine (Oncovin)FDA LinkGeneric
08/2007
1Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2007
1Etoposide (VP 16)FDA LinkGeneric
08/2007
1Hormones (Hormone)IBA
07/2007
1Glutathione (Reduced Glutathione)IBA
07/2007
1Small Interfering RNA (siRNA)IBA
04/2007
1OligonucleotidesIBA
04/2007
1Carrier Proteins (Binding Protein)IBA
03/2006
1AntigensIBA
03/2006
1Cell Adhesion MoleculesIBA
01/2004
1EndotoxinsIBA
08/2003
1SolutionsIBA
04/2003
1Lidocaine (Xylocaine)FDA LinkGeneric
04/2003
1Biological ProductsIBA
12/2001
1Thymidylate SynthaseIBA
12/2001
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
12/2001
1Shiga Toxin (Shigella Toxin)IBA
09/2001
1urtoxazumabIBA
09/2001
1Immunoglobulins (Immunoglobulin)IBA
06/2001
1DNA (Deoxyribonucleic Acid)IBA
02/2001
1HMGB1 Protein (HMG1)IBA
02/2001
1ErbB Receptors (EGF Receptor)IBA
01/2001
1TeicoplaninIBA
12/2000
1SteroidsIBA
12/2000
1AlbuminsIBA
12/2000
1Messenger RNA (mRNA)IBA
09/2000
1tissue-factor-pathway inhibitor 2 (PP5)IBA
09/2000
1Cholinergic Agents (Cholinergics)IBA
08/2000
1Hexamethonium (Hexamethonium Bromide)IBA
08/2000
1Fibroins (Fibroin)IBA
08/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2000

Therapy/Procedure

2Ligation
04/2011 - 11/2003
1Therapeutics
01/2012
1Chronotherapy
07/2007
1Lasers (Laser)
04/2003
1Cardiac Procedures Anesthesia
12/2001
1Drug Therapy (Chemotherapy)
09/2001
1Pleurodesis
12/2000
1Catheters
08/2000
1Sutures (Suture)
08/2000